UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended July 28, 2019
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from ___ to ___
Commission file number 0-15451
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation or organization) |
(IRS Employer Identification No.) |
(Address of principal executive offices) |
(Zip Code) |
Registrant’s telephone number, including area code |
( |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
☒ |
Accelerated Filer |
☐ |
Non-Accelerated Filer |
☐ |
|
Smaller Reporting Company |
Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ☐ No ☒
The registrant had 67,196,843 shares of common stock outstanding as of August 30, 2019.
Forward-Looking Statements
The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements made by or on behalf of Photronics, Inc. (“Photronics”, the “Company”, “we”, “our”, or “us”). These statements are based on management’s beliefs, as well as assumptions made by, and information currently available to, management. Forward-looking statements may be identified by words like “expect,” “anticipate,” “believe,” “plan,” “project,” “could,” “estimate,” “intend,” “may,” “will” and similar expressions, or the negative of such terms, or other comparable terminology. All forward-looking statements involve risks and uncertainties that are difficult to predict. In particular, any statement contained in this quarterly report on Form 10-Q or in other documents filed with the Securities and Exchange Commission in press releases or in the Company’s communications and discussions with investors and analysts in the normal course of business through meetings, phone calls, or conference calls regarding, among other things, the consummation and benefits of transactions, joint ventures, business combinations, divestitures and acquisitions, expectations with respect to future sales, financial performance, operating efficiencies, or product expansion, are subject to known and unknown risks, uncertainties, and contingencies, many of which are beyond the control of the Company. Various factors may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements expressed or implied by forward-looking statements. Factors that might affect forward-looking statements include, but are not limited to, overall economic, business, and political conditions in both domestic as well as international markets; the demand for the Company’s products; competitive factors in the industries and geographic markets in which the Company competes; the timing of orders received from customers; the gain or loss of significant customers; competition from other manufacturers; changes in accounting standards; federal, state and international tax requirements (including tax rate changes, new tax laws and revised tax law interpretations); changes in the jurisdictional mix of our earnings and changes in tax laws and rates; interest rate and other capital market conditions, including changes in the market price of the Company’s securities; foreign currency exchange rate fluctuations; changes in technology; technology or intellectual property infringement, including cybersecurity breaches, and other innovation risks; unsuccessful or unproductive research and development or capital expenditures; the timing, impact, and other uncertainties related to transactions and acquisitions, divestitures, business combinations, and joint ventures as well as decisions the Company may make in the future regarding the Company’s business, capital and organizational structures and other matters; the seasonal and cyclical nature of the semiconductor and flat panel display industries; management changes; changes in laws and government regulation impacting our operations or our products, including laws relating to export controls and import laws, rules and tariffs; the occurrence of regulatory proceedings, claims or litigation; damage or destruction to the Company’s facilities, or the facilities of its customers or suppliers, by natural disasters, labor strikes, political unrest, or terrorist activity; construction of new facilities and assembly of new equipment; dilutive issuances of the Company’s stock; the ability of the Company to (i) place new equipment in service on a timely basis; (ii) obtain additional financing; (iii) achieve anticipated synergies and cost savings; (iv) fully utilize its tools; (v) achieve desired yields, pricing, product mix, and market acceptance of its products and (vi) obtain necessary import and export licenses. Any forward-looking statements should be considered in light of these factors. Accordingly, there is no assurance that the Company’s expectations will be realized. The Company does not assume responsibility for the accuracy and completeness of the forward-looking statements and does not assume an obligation to provide revisions to any forward-looking statements, except as otherwise required by securities and other applicable laws.
PHOTRONICS, INC.
PART I. |
FINANCIAL INFORMATION |
|
Item 1. |
4 |
|
4 |
||
5 |
||
6 |
||
7 |
||
9 |
||
10 |
||
Item 2. |
25 |
|
Item 3. |
32 |
|
Item 4. |
32 |
|
PART II. |
OTHER INFORMATION |
|
Item 1A. |
33 |
|
Item 2. |
33 |
|
Item 5. |
33 |
|
Item 6. |
34 |
PART I. FINANCIAL INFORMATION
PHOTRONICS, INC.
(in thousands, except per share amounts)
(unaudited)
July 28, 2019 |
October 31, 2018 |
|||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ |
$ |
||||||
Accounts receivable, net of allowance of $ |
||||||||
Inventories |
||||||||
Prepaid expenses |
||||||||
Other current assets |
||||||||
Total current assets |
||||||||
Property, plant and equipment, net |
||||||||
Intangible assets, net |
||||||||
Deferred income taxes |
||||||||
Other assets |
||||||||
Total assets |
$ |
$ |
||||||
LIABILITIES AND EQUITY |
||||||||
Current liabilities: |
||||||||
Short-term debt |
$ |
$ |
||||||
Current portion of long-term debt |
||||||||
Accounts payable |
||||||||
Accrued liabilities |
||||||||
Total current liabilities |
||||||||
Long-term debt |
||||||||
Deferred income taxes |
||||||||
Other liabilities |
||||||||
Total liabilities |
||||||||
Commitments and contingencies |
||||||||
Equity: |
||||||||
Preferred stock, $ |
||||||||
Common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Retained earnings |
||||||||
Treasury stock, |
( |
) |
( |
) |
||||
Accumulated other comprehensive loss |
( |
) |
( |
) |
||||
Total Photronics, Inc. shareholders’ equity |
||||||||
Noncontrolling interests |
||||||||
Total equity |
||||||||
Total liabilities and equity |
$ |
$ |
||||||
See accompanying notes to condensed consolidated financial statements.
PHOTRONICS, INC.
(in thousands, except per share amounts)
(unaudited)
Three Months Ended |
Nine Months Ended |
|||||||||||||||
July 28, 2019 |
July 29, 2018 |
July 28, 2019 |
July 29, 2018 |
|||||||||||||
Revenue |
$ |
$ |
$ |
$ |
||||||||||||
Cost of goods sold |
||||||||||||||||
Gross profit |
||||||||||||||||
Operating expenses: |
||||||||||||||||
Selling, general and administrative |
||||||||||||||||
Research and development |
||||||||||||||||
Total operating expenses |
||||||||||||||||
Operating income |
||||||||||||||||
Other income (expense): |
||||||||||||||||
Interest income and other income (expense), net |
||||||||||||||||
Interest expense |
( |
) |
( |
) |
( |
) |
( |
) |
||||||||
Income before income taxes |
||||||||||||||||
Income tax provision |
||||||||||||||||
Net income |
||||||||||||||||
Net income attributable to noncontrolling interests |
||||||||||||||||
Net income attributable to Photronics, Inc. shareholders |
$ |
$ |
$ |
$ |
||||||||||||
Earnings per share: |
||||||||||||||||
Basic |
$ |
$ |
$ |
$ |
||||||||||||
Diluted |
$ |
$ |
$ |
$ |
||||||||||||
Weighted-average number of common shares outstanding: |
||||||||||||||||
Basic |
||||||||||||||||
Diluted |
||||||||||||||||
See accompanying notes to condensed consolidated financial statements.
PHOTRONICS, INC.
(in thousands)
(unaudited)
Three Months Ended |
Nine Months Ended |
|||||||||||||||
July 28, 2019 |
July 29, 2018 |
July 28, 2019 |
July 29, 2018 |
|||||||||||||
Net income |
$ |
$ |
$ |
$ |
||||||||||||
Other comprehensive (loss) income, net of tax of $ |
||||||||||||||||
Foreign currency translation adjustments |
( |
) |
( |
) |
( |
) |
( |
) |
||||||||
Amortization of cash flow hedge |
||||||||||||||||
Other |
||||||||||||||||
Net other comprehensive loss |
( |
) |
( |
) |
( |
) |
( |
) |
||||||||
Comprehensive income (loss) |
( |
) |
||||||||||||||
Less: comprehensive income attributable to noncontrolling interests |
||||||||||||||||
Comprehensive (loss) income attributable to Photronics, Inc. shareholders |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
||||||||
See accompanying notes to condensed consolidated financial statements.
PHOTRONICS, INC.
(in thousands)
(unaudited)
Three Months Ended July 28, 2019 |
||||||||||||||||||||||||||||||||
Photronics, Inc. Shareholders |
||||||||||||||||||||||||||||||||
Common Stock |
Additional Paid-in |
Retained |
Treasury |
Accumulated Other Comprehensive |
Non- controlling |
Total |
||||||||||||||||||||||||||
Shares |
Amount |
Capital |
Earnings |
Stock |
Loss |
Interests |
Equity |
|||||||||||||||||||||||||
Balance at April 29, 2019 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
|||||||||||||||||||||
Net income |
- |
|||||||||||||||||||||||||||||||
Other comprehensive loss |
- |
( |
) |
( |
) |
( |
) |
|||||||||||||||||||||||||
Sale of common stock through employee stock option and purchase plans |
||||||||||||||||||||||||||||||||
Restricted stock awards vesting and expense |
||||||||||||||||||||||||||||||||
Share-based compensation expense |
- |
|||||||||||||||||||||||||||||||
Repurchase of common stock of subsidiary |
- |
( |
) |
( |
) |
|||||||||||||||||||||||||||
Balance at July 28, 2019 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
|||||||||||||||||||||
Three Months Ended July 29, 2018 |
||||||||||||||||||||||||||||||||
Photronics, Inc. Shareholders |
||||||||||||||||||||||||||||||||
Common Stock |
Additional Paid-in |
Retained |
Treasury |
Accumulated Other Comprehensive |
Non- controlling |
Total |
||||||||||||||||||||||||||
Shares |
Amount |
Capital |
Earnings |
Stock |
Income |
Interests |
Equity |
|||||||||||||||||||||||||
Balance at April 30, 2018 |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||||
Net income |
- |
|||||||||||||||||||||||||||||||
Other comprehensive loss |
- |
( |
) |
( |
) |
( |
) |
|||||||||||||||||||||||||
Sale of common stock through employee stock option and purchase plans |
||||||||||||||||||||||||||||||||
Restricted stock awards vesting and expense |
||||||||||||||||||||||||||||||||
Share-based compensation expense |
- |
|||||||||||||||||||||||||||||||
Contribution from noncontrolling interest |
- |
|||||||||||||||||||||||||||||||
Purchase of treasury stock |
- |
( |
) |
( |
) |
|||||||||||||||||||||||||||
Balance at July 29, 2018 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
$ |
|||||||||||||||||||||||
See accompanying notes to condensed consolidated financial statements.
PHOTRONICS, INC.
Condensed Consolidated Statements of Equity (continued)
(in thousands)
(unaudited)
Nine Months Ended July 28, 2019 |
||||||||||||||||||||||||||||||||
Photronics, Inc. Shareholders |
||||||||||||||||||||||||||||||||
Common Stock |
Additional Paid-in |
Retained |
Treasury |
Accumulated Other Comprehensive |
Non- controlling |
Total |
||||||||||||||||||||||||||
Shares |
Amount |
Capital |
Earnings |
Stock |
Loss |
Interests |
Equity |
|||||||||||||||||||||||||
Balance at November 1, 2018 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
|||||||||||||||||||||
Adoption of ASU 2014-09 |
- |
|||||||||||||||||||||||||||||||
Adoption of ASU 2016-16 |
- |
( |
) |
( |
) |
( |
) |
|||||||||||||||||||||||||
Net income |
- |
|||||||||||||||||||||||||||||||
Other comprehensive (loss) income |
- |
( |
) |
( |
) |
|||||||||||||||||||||||||||
Sale of common stock through employee stock option and purchase plans |
||||||||||||||||||||||||||||||||
Restricted stock awards vesting and expense |
||||||||||||||||||||||||||||||||
Share-based compensation expense |
- |
|||||||||||||||||||||||||||||||
Contribution from noncontrolling interest |
- |
|||||||||||||||||||||||||||||||
Dividends to noncontrolling interest |
- |
( |
) |
( |
) |
|||||||||||||||||||||||||||
Repurchase of common stock of subsidiary |
- |
( |
) |
( |
) |
|||||||||||||||||||||||||||
Purchase of treasury stock |
- |
( |
) |
( |
) |
|||||||||||||||||||||||||||
Balance at July 28, 2019 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
|||||||||||||||||||||
Nine Months Ended July 29, 2018 |
||||||||||||||||||||||||||||||||
Photronics, Inc. Shareholders |
||||||||||||||||||||||||||||||||
Common Stock |
Additional Paid-in |
Retained |
Treasury |
Accumulated Other Comprehensive |
Non- controlling |
Total |
||||||||||||||||||||||||||
Shares |
Amount |
Capital |
Earnings |
Stock |
Income |
Interests |
Equity |
|||||||||||||||||||||||||
Balance at October 30, 2017 |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||||
Net income |
- |
|||||||||||||||||||||||||||||||
Other comprehensive loss |
- |
( |
) |
( |
) |
( |
) |
|||||||||||||||||||||||||
Sale of common stock through employee stock option and purchase plans |
||||||||||||||||||||||||||||||||
Restricted stock awards vesting and expense |
||||||||||||||||||||||||||||||||
Share-based compensation expense |
- |
|||||||||||||||||||||||||||||||
Contribution from noncontrolling interest |
- |
|||||||||||||||||||||||||||||||
Dividends to noncontrolling interest |
- |
( |
) |
( |
) |
|||||||||||||||||||||||||||
Purchase of treasury stock |
- |
( |
) |
( |
) |
|||||||||||||||||||||||||||
Balance at July 29, 2018 |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
$ |
|||||||||||||||||||||||
See accompanying notes to condensed consolidated financial statements.
PHOTRONICS, INC.
(in thousands)
(unaudited)
Nine Months Ended |
||||||||
July 28, 2019 |
July 29, 2018 |
|||||||
Cash flows from operating activities: |
||||||||
Net income |
$ |
$ |
||||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Depreciation and amortization |
||||||||
Changes in assets and liabilities: |
||||||||
Accounts receivable |
( |
) |
( |
) |
||||
Inventories |
( |
) |
( |
) |
||||
Other current assets |
( |
) |
( |
) |
||||
Accounts payable, accrued liabilities, and other |
( |
) |
||||||
Net cash provided by operating activities |
||||||||
Cash flows from investing activities: |
||||||||
Purchases of property, plant and equipment |
( |
) |
( |
) |
||||
Government incentives |
||||||||
Other |
( |
) |
* |
|||||
Net cash used in investing activities |
( |
) |
( |
)* |
||||
Cash flows from financing activities: |
||||||||
Proceeds from debt |
||||||||
Contribution from noncontrolling interest |
||||||||
Repayments of debt |
( |
) |
( |
) |
||||
Dividends paid to noncontrolling interest |
( |
) |
( |
) |
||||
Purchase of treasury stock |
( |
) |
( |
) |
||||
Proceeds from share-based arrangements |
||||||||
Other |
( |
) |
( |
) |
||||
Net cash (used in) provided by financing activities |
( |
) |
||||||
Effect of exchange rate changes on cash, cash equivalents, and restricted cash |
( |
)* |
||||||
Net (decrease) increase in cash, cash equivalents, and restricted cash |
( |
) |
* |
|||||
Cash, cash equivalents, and restricted cash at beginning of period |
* |
* |
||||||
Cash, cash equivalents, and restricted cash at end of period |
$ |
$ |
* |
|||||
Supplemental disclosure information: |
||||||||
Accrual for property, plant and equipment purchased during the period |
$ |
$ |
||||||
Accrual for property, plant and equipment purchased with funds receivable from government incentives |
$ |
$ |
||||||
Subsidiary dividend payable |
$ |
$ |
||||||
* Amount has been modified to reflect the adoption of ASU 2016-18 (see Note 14).
See accompanying notes to condensed consolidated financial statements.
PHOTRONICS, INC.
Three Months and Nine Months Ended July 28, 2019 and July 29, 2018
(unaudited)
(in thousands, except share amounts and per share data)
NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION
Photronics, Inc. ("Photronics", "the Company", "we", “our”, or "us") is one of the world's leading manufacturers of photomasks, which are high-precision photographic quartz or glass plates containing microscopic images of electronic circuits. Photomasks are a key element in the manufacture of semiconductors and flat-panel displays ("FPDs"), and are used as masters to transfer circuit patterns onto semiconductor wafers and FPD substrates during the fabrication of integrated circuits ("ICs" or “semiconductors”) and a variety of FPDs and, to a lesser extent, other types of electrical and optical components. We currently have eleven manufacturing facilities, which are located in Taiwan (3 ), Korea, the United States (3 ), Europe (2 ), and two recently constructed facilities in China. Our FPD Facility in Hefei, China, commenced production in the second quarter of our fiscal 2019; our IC facility in Xiamen, China, commenced production in the third quarter of our fiscal 2019.
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of management, adjustments, all of which are of a normal recurring nature, considered necessary for a fair presentation have been included. Our business is typically impacted during the first, and sometimes the second, quarter of our fiscal year by the North American, European, and Asian holiday periods, as some customers reduce their development and buying activities during those periods. Operating results for the interim period are not necessarily indicative of the results that may be expected for the fiscal year ending October 31, 2019. For further information, refer to the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended October 31, 2018.
NOTE 2 - INVENTORIES
July 28, 2019 |
October 31, 2018 |
|||||||
Raw materials |
$ |
$ |
||||||
Work in process |
||||||||
Finished goods |
||||||||
$ |
$ |
|||||||
NOTE 3 - PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment consists of the following:
July 28, 2019 |
October 31, 2018 |
|||||||
Land |
$ |
$ |
||||||
Buildings and improvements |
||||||||
Machinery and equipment |
||||||||
Leasehold improvements |
||||||||
Furniture, fixtures and office equipment |
||||||||
Construction in progress |
||||||||
Accumulated depreciation and amortization |
( |
) |
( |
) |
||||
$ |
$ |
|||||||
Depreciation and amortization expense for property, plant and equipment was $20.7 million and $56.9 million in the three- and nine-month periods ended July 28, 2019, respectively, and $18.9 million and $60.8 million in the three- and nine-month periods ended July 29, 2018, respectively.
In January 2017, we entered into a noncash transaction with a customer which resulted in the acquisition of equipment with fair values of approximately $6.7 million during the nine-month period ended July 29, 2018.
NOTE 4 - PDMCX JOINT VENTURE
In January 2018, Photronics, through its wholly owned Singapore subsidiary (hereinafter, within this Note “we”, or “Photronics”), and Dai Nippon Printing Co., Ltd., through its wholly owned subsidiary “DNP Asia Pacific PTE, Ltd.” (hereinafter, within this Note, “DNP”) entered into a joint venture under which DNP obtained a 49.99 % interest in our recently established IC business in Xiamen, China, which commenced production in the third quarter of 2019. The joint venture, known as “Xiamen American Japan Photronics Mask Co., Ltd.” (hereinafter, “PDMCX”), was established to develop and manufacture photomasks for leading edge and advanced generation semiconductors. We entered into this joint venture to enable us to compete more effectively for the merchant photomask business in China, and to benefit from the additional resources and investment that DNP provides to enable us to offer advanced-process technology to our customers. No
The total investment per the PDMCX operating agreement (“the Agreement”) is $160 million. As of July 28, 2019, Photronics and DNP had each contributed cash of approximately $48 35 million. The remaining $29 million investment will be funded, over the next several quarters, with additional local financing of $15 million and approximately $14 million of cash contributions from Photronics and DNP.
Under the Agreement, DNP is afforded, under certain circumstances, the right to put its interest in PDMCX to Photronics. These circumstances include disputes regarding the strategic direction of PDMCX that may arise after the initial two-year term of the Agreement and cannot be resolved between the two parties. In addition, both Photronics and DNP have the option to purchase, or put, their interest from, or to, the other party, should their ownership interest fall below for a period of more than consecutive months. Under all such circumstances, the sales of ownership interests would be at the exiting party’s ownership percentage of the joint venture’s net book value, with closing to take place within business days of obtaining required approvals and clearance.
We recorded net losses from the operations of PDMCX of approximately $1.3 million, and $3.2 million during the three and nine-month periods ended July 28, 2019, respectively, and $0.2 million and $0.9 million in the three and nine-month periods ended July 29, 2018, respectively. General creditors of PDMCX do no t have recourse to the assets of Photronics, Inc., and our maximum exposure to loss from PDMCX at July 28, 2019, was $42.5 million.
The carrying amounts of PDMCX assets and liabilities included in our condensed consolidated balance sheets are presented in the following table, together with our exposure to loss related to these assets and liabilities.
July 28, 2019 |
October 31, 2018 |
|||||||||||||||
Classification |
Carrying Amount |
Photronics Interest |
Carrying Amount |
Photronics Interest |
||||||||||||
Current assets |
$ |
$ |
$ |
$ |
||||||||||||
Non-current assets |
||||||||||||||||
Total assets |
||||||||||||||||
Current liabilities |
||||||||||||||||
Non-current liabilities |
||||||||||||||||
Total liabilities |
||||||||||||||||
Net assets |
$ |
$ |
$ |
$ |
||||||||||||
NOTE 5 – DEBT
July 28, 2019 |
October 31, 2018 |
|||||||
Project Loans |
$ |
$ |
||||||
Working Capital Loans |
||||||||
Current portion |
( |
) |
( |
) |
||||
$ |
$ |
|||||||
In November 2018, PDMCX was approved for credit of $50 million, subject to certain limitations related to PDMCX registered capital at the time of the initial approval, pursuant to which PDMCX has and will enter into separate loan agreements (“the Project Loans”) for intermittent borrowings. The Project Loans, which are denominated in Chinese renminbi (RMB), are being used to finance certain capital expenditures in China. PDMCX granted liens on its land, building, and certain equipment as collateral for the Project Loans. As of July 28, 2019, PDMCX had borrowed 243.4 million RMB ($35.4 million) against this approval, which includes $9.6 million borrowed during the three-month period ended July 28, 2019. Payments on these borrowings are due semi-annually through December 2025; the initial payment is scheduled for June 2020. The table below presents, in U.S. dollars, the timing of future payments against the borrowings.
Fiscal Year |
||||||||||||||||||||||||||||
2020 (all within one year of July 28, 2019) |
2021 |
2022 |
2023 |
2024 |
2025 |
2026 |
||||||||||||||||||||||
Principal payments |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||
The interest rates on the Project Loans are based on the benchmark lending rate of the People’s Bank of China (4.9 % at July 28, 2019). Interest incurred on the loans will be reimbursed through incentives provided by the Xiamen Torch Hi-Tech Industrial Development Zone, which provide for such reimbursements up to a prescribed limit.
In November 2018, PDMCX received approval for unsecured credit of $25.0 million, pursuant to which PDMCX may enter into separate loan agreements. Under this credit agreement (the “Working Capital Loan”), PDMCX can borrow up to 140.0 million RMB, or approximately $20.4 million, to pay value-added taxes (“VAT”) and up to 60.0 million RMB ($8.7 million) to fund operations; combined total borrowings are limited to $25.0 million. Through July 28, 2019, PDMCX borrowed 68.0 million RMB ($9.9 million) to pay VAT. Payments on these borrowings are due semiannually, at an increasing rate, through January 2022; PDMCX made installment payments totaling $0.1 million during the three-month period ended July 28, 2019. The table below presents, in U.S. dollars, the timing of future payments against these borrowings.
Fiscal Year 2020 (all within one year of July 28, 2019) |
Fiscal Year 2021 |
Fiscal Year 2022 |
||||||||||
Principal payments |
$ |
$ |
$ |
|||||||||
In addition, during the quarter ended July 28, 2019, PDMCX borrowed 11.4 million RMB ($3.9 million) against this approval to fund operations, with repayments due one year from the borrowing dates.
The interest rates on borrowings to fund operations is approximately 4.6 % and interest rates on borrowings to pay VAT are approximately 5.0 %; both rates are based on the RMB Loan Prime Rate of the National Interbank Funding Center, plus a spread of 67.75 basis points. Interest incurred on the loans will be reimbursed through incentives provided by the Xiamen Torch Hi-Tech Industrial Development Zone, which provide for such reimbursements up to a prescribed limit.
In January 2015, we privately exchanged $57.5 million in aggregate principal amount of our 3.25 % convertible senior notes with a maturity date of April 1, 2016 , for new 3.25 % convertible senior notes with an aggregate principal amount of $57.5 million with a maturity date of April 1, 2019 . The conversion rate of the new notes was the same as that of the exchanged notes, which were issued in March 2011 with a conversion rate of approximately 96 1,000 10.37 57.5 million principal amount was repaid upon maturity.
In September 2018, we entered into a five-year amended and restated credit agreement (“the credit agreement”), which has a $50 million borrowing limit, with an expansion capacity to $100 million. The credit agreement is secured by substantially all of our assets located in the United States and common stock we own in certain foreign subsidiaries. The credit agreement includes minimum interest coverage ratio, total leverage ratio, and minimum unrestricted cash balance covenants (all of which we were in compliance with at July 28, 2019), and limits the amount of dividends, distributions, and redemptions we can pay on our stock to an aggregate amount of $100 million. We had no outstanding borrowings against the credit agreement at July 28, 2019, and $50 million was available for borrowing. The interest rate on the credit agreement (2.5 % at July 28, 2019) is based on our total leverage ratio at LIBOR plus a spread, as defined in the credit agreement.
Effective July 25, 2019, the Company entered into a Master Lease Agreement (“MLA”) which enables us to request advance payments or other funds for equipment or enter into an equipment lease in the U.S. In connection with this MLA, we were approved for financing of $35 million for the purchase of equipment; as of July 28, 2019, we had outstanding borrowings against this MLA. In the fourth quarter of fiscal 2019, the financing entity, upon our request, made an advance payment of $3.4 million to an equipment vendor on our behalf. Interest on this borrowing is payable monthly at thirty-day LIBOR plus 1 %, and will continue to accrue until the borrowing is repaid or, as allowed under the MLA, we enter into a lease for the equipment. All borrowings under the MLA are secured by the equipment purchased or financed.
NOTE 6 - REVENUE
We adopted Accounting Standards Update 2014-09 and all subsequent amendments which are collectively codified in Accounting Standards Codification Topic 606 - “Revenue from Contracts with Customers” (“Topic 606”) - on November 1, 2018, under the modified retrospective transition method, only with respect to contracts that were not complete as of the date of adoption. This approach required prospective application of the guidance with a cumulative effect adjustment to retained earnings to reflect the impact of the adoption on contracts that were not complete as of the date of the adoption. In accordance with the modified retrospective transition method, the results of the prior year period presented have not been adjusted for the effects of Topic 606.
Under Topic 606, we recognize revenue when, or as, control of a good or service transfers to a customer, in an amount that reflects the consideration to which we expect to be entitled in exchange for transferring those goods or services, whereas, prior to our adoption of Topic 606, we recognized revenue when we shipped to customers or, under some arrangements, when the customers received the goods. The following tables present the impacts of our adoption of Topic 606 on our July 28, 2019, condensed consolidated balance sheet, and condensed consolidated statements of income for the three and nine months ended July 28, 2019, and cash flows for the nine-months ended July 28, 2019.
Condensed Consolidated Balance Sheet
July 28, 2019
As Reported |
Adjustments |
Balance without Adoption of Topic 606 |
||||||||||
Assets |
||||||||||||
Accounts receivable |
$ |
$ |
( |
) |
$ |
|||||||
Inventory |
||||||||||||
Other current assets |
( |
) |
||||||||||
Deferred income taxes |
||||||||||||
Liabilities |
||||||||||||
Accrued liabilities |
$ |
$ |
$ |
|||||||||
Deferred income taxes |
( |
) |
||||||||||
Equity |
||||||||||||
Photronics, Inc. shareholders’ equity |
$ |
$ |
( |
) |
$ |
|||||||
Noncontrolling interests |
( |
) |
||||||||||
Condensed Consolidated Statement of Income
Three Months Ended July 28, 2019
As Reported |
Adjustments |
Balance without Adoption of Topic 606 |
||||||||||
Revenue |
$ |
$ |
$ |
|||||||||
Cost of goods sold |
||||||||||||
Gross profit |
||||||||||||
Provision for taxes |
( |
) |
||||||||||
Net income |
||||||||||||
Noncontrolling interests |
||||||||||||
Income attributable to Photronics, Inc. shareholders |
$ |
$ |
$ |
|||||||||
Condensed Consolidated Statement of Income
Nine Months Ended July 28, 2019
As Reported |
Adjustments |
Balance without Adoption of Topic 606 |
||||||||||
Revenue |
$ |
$ |
( |
) |
$ |
|||||||
Cost of goods sold |
( |
) |
||||||||||
Gross profit |
( |
) |
||||||||||
Provision for taxes |
( |
) |
||||||||||
Net income |
( |
) |
||||||||||
Noncontrolling interests |
( |
) |
||||||||||
Income attributable to Photronics, Inc. shareholders |
$ |
$ |
( |
) |
$ |
|||||||
Condensed Consolidated Statement of Cash Flows
Nine Months Ended July 28, 2019
As Reported |
Adjustments |
Balance without Adoption of Topic 606 |
||||||||||
Net Income |
$ |
$ |
( |
) |
$ |
|||||||
Changes in operating accounts: |
||||||||||||
Accounts receivable |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
|||
Inventories |
( |
) |
( |
) |
( |
) |
||||||
Other current assets |
( |
) |
( |
) |
||||||||
Accounts payable, accrued liabilities, and other |
( |
) |
( |
) |
||||||||
As stated above, photomasks are manufactured in accordance with proprietary designs provided by our customers; thus, they are individually unique. Due to their uniqueness and other factors, their transaction prices are individually established through negotiations with customers; consequently, our photomasks do not have standard or “list” prices. The transaction prices of the vast majority of our revenue contracts include only fixed amounts of consideration. In certain instances, such as when we offer a customer an early payment discount, an estimate of variable consideration would be included in the transaction price, but only to the extent that a significant reversal of revenue would not occur when the uncertainty related to the variability is resolved.
We recognize a contract asset when our performance under a contract precedes our receipt of consideration from a customer, or before payment is due, and our receipt of consideration is conditional upon factors other than the passage of time. Contract assets reflect our transfer of control to customers of photomasks that are in process or completed but not yet shipped. A receivable is recognized when we have an unconditional right to payment for our performance, which generally occurs when we ship the photomasks. Our contract assets primarily consist of a significant amount of our work-in-process inventory and fully manufactured photomasks which have not yet shipped, for which we have an enforceable right to collect consideration (including a reasonable profit) in the event the in-process orders are cancelled by customers. On an individual contract basis, we net contract assets with contract liabilities (deferred revenue) for financial reporting purposes. Our contract assets and liabilities are typically classified as current, as our production cycle and our lead times are both under one year. Contract assets of $6.2 million are included in “Other” current assets, and contract liabilities of $10.2 million are included in “Other” current liabilities in our July 28, 2019 condensed consolidated balance sheet. At November 1, 2018, our date of adoption of Topic 606, we had contract assets of $4.6 million and contract liabilities of $7.8 million. We did no t impair any contract assets during the nine-month period ended July 28, 2019, and, during the respective three and nine-month periods ended July 28, 2019, we recognized $0.8 million and $1.1 million of revenue from the settlement of contract liabilities that existed at the beginning of those periods.
We generally record our accounts receivable at their billed amounts. All outstanding past due customer invoices are reviewed during, and at the end of, every period for collectibility. To the extent we believe a loss on the collection of a customer invoice is probable, we record the loss and credit the allowance for doubtful accounts. In the event that an amount is determined to be uncollectible, we charge the allowance for doubtful accounts and derecognize the related receivable. Credit losses incurred on our accounts receivable during the nine-month period ended July 28, 2019 were immaterial.
Our invoice terms generally range from net to ninety days , depending on both the geographic market in which the transaction occurs and our payment agreements with specific customers. In the event that our evaluation of a customer’s business prospects and financial condition indicate that the customer presents a collectibility risk, we require payment in advance of performance. We have elected the practical expedient allowed under Topic 606 that permits us not to adjust a contract’s promised amount of consideration to reflect a financing component when the period between when we transfer control of goods or services to customers and when we are paid is one year or less.
In instances when we are paid in advance of our performance, we record a contract liability and, as allowed under the practical expedient in Topic 606, recognize interest expense only if the period between when we receive payment from the customer and the date when we expect to be entitled to the payment is greater than one year. Historically, advance payments we’ve received from customers have not preceded the completion of our performance obligations by more than one year.
Disaggregation of Revenue
Revenue by Product Type |
Three Months Ended July 28, 2019 |
Nine Months Ended July 28, 2019 |
||||||
IC |
||||||||
High-end |
$ |
$ |
||||||
Mainstream |
||||||||
Total IC |
$ |
$ |
||||||
FPD |
||||||||
High-end |
$ |
$ |
||||||
Mainstream |
||||||||
Total FPD |
$ |
$ |
||||||
$ |
$ |
|||||||
Revenue by Geographic Location |
||||||||
Taiwan |
$ |
$ |
||||||
Korea |
||||||||
United States |
||||||||
Europe |
||||||||
China |
||||||||
Other |
||||||||
$ |
$ |
|||||||
Revenue by Timing of Recognition |
||||||||
Over time |
$ |
$ |
||||||
At a point in time |
||||||||
$ |
$ |
|||||||
We pay commissions to third party sales agents for certain sales that they obtain for us. However, the bases of the commissions are the transaction prices of the sales, which are completed in less than one year; thus, no relationship is established with a customer that will result in future business. Therefore, we would not recognize any portion of these sales commissions as costs of obtaining a contract, nor do we currently foresee other circumstances under which we would recognize such assets.
Remaining Performance Obligations
As we are typically required to fulfill customer orders within a short time period, our backlog of orders is generally not in excess of one to two weeks for IC photomasks and two to three weeks for FPD photomasks. As allowed under Topic 606, we have elected not to disclose our remaining performance obligations, which represent the costs associated with the completion of the manufacturing process of in-process photomasks related to contracts that have an original duration of one year or less.
Sales and Similar Taxes
We report our revenue net of any sales or similar taxes we collect on behalf of governmental entities.
Product Warranty
Our photomasks are sold under warranties that generally range from 1 to 24 months . We warrant that our photomasks conform to customer specifications, and will typically repair, replace, or issue a refund, at our option, any photomasks that fail to do so. The warranties do not represent separate performance obligations in our revenue contracts. Historically, customer claims under warranty have been immaterial.
NOTE 7 - SHARE-BASED COMPENSATION
In March 2016, shareholders approved a new equity incentive compensation plan (the “Plan”), under which incentive stock options, non-qualified stock options, stock grants, stock-based awards, restricted stock, restricted stock units, stock appreciation rights, performance units, performance stock, and other stock or cash awards may be granted. Shares to be issued under the Plan may be authorized and unissued shares, issued shares we have reacquired (in the open-market or in private transactions), shares held in the treasury, or a combination thereof. The maximum number of shares of common stock approved that may be issued under the Plan is shares. Awards may be granted to officers, employees, directors, consultants, advisors, and independent contractors of Photronics or its subsidiaries. In the event of a change in control (as defined in the Plan), the vesting of awards may be accelerated. The Plan, aspects of which are more fully described below, prohibits further awards from being issued under prior plans. Total share-based compensation costs for the three and nine-month periods ended July 28, 2019, were $0.9 million and $2.9 million, respectively, and $0.8 million and $2.4 million for the three and nine-month periods ended July 29, 2018, respectively. The Company received cash from option exercises of $0.2 million and $1.0 million for the three and nine-month periods ended July 28, 2019, respectively, and $0.2 million and $3.8 million for the three and nine-month periods ended July 29, 2018, respectively. No no
Stock Options
There were no share options granted during the three-month period ended July 28, 2019, and there were 12,000 options granted during the three-month period ended July 29, 2018, with a weighted-average grant-date fair value of $2.84 per share. There were 132,000 share options granted during the nine-month period ended July 28, 2019, with a weighted-average grant-date fair value of $3.31 per share, and 264,000 share options granted during the nine-month period ended July 29, 2018, with a weighted-average grant-date fair value of $2.74 per share. As of July 28, 2019, the total unrecognized compensation cost related to unvested option awards was approximately $1.0 million. That cost is expected to be recognized over a weighted-average amortization period of 2.3 years.
Three Months Ended |
Nine Months Ended |
||||||||||||||
July 28, 2019 |
July 29, 2018 |
July 28, 2019 |
July 29, 2018 |
||||||||||||
Volatility |
N/A |
||||||||||||||
Risk free rate of return |
N/A |
||||||||||||||
Dividend yield |
N/A |
||||||||||||||
Expected term |
N/A |
||||||||||||||
Options |
Shares |
Weighted Average Exercise Price |
Weighted Average Remaining Contractual Life |
Aggregate Intrinsic Value |
|||||||||
Outstanding at July 28, 2019 |
$ |
$ |
|||||||||||
Exercisable at July 28, 2019 |
$ |
$ |
|||||||||||
Restricted Stock
We periodically grant restricted stock awards, the restrictions on which typically lapse over a service period of one to four years . The fair value of an award is determined on the date of grant, based on the closing price of our common stock. There were 435,000 restricted stock awards granted during the nine-month period ended July 28, 2019, with a weighted-average grant-date fair value of $9.80 per share. There were no 290,000 restricted stock awards granted during the nine-month period ended July 29, 2018, with a weighted-average grant-date fair value of $8.62 per share. As of July 28, 2019, the total compensation cost not yet recognized related to unvested restricted stock awards was approximately $5.0 million. That cost is expected to be recognized over a weighted-average amortization period of 2.7 years. As of July 28, 2019, there were 676,863 shares of restricted stock outstanding.
NOTE 8 - INCOME TAXES
The effective tax rate of 24.7 % in the three-month period ended July 28, 2019, differs from the U.S. statutory rate of 21.0 %, primarily due to the elimination of tax benefits in jurisdictions, including the U.S., in which it is not more likely than not that the benefit will be realized; the effects of these eliminations were partially offset by the benefits of tax holidays and investment credits in certain foreign jurisdictions.
The effective tax rate of 22.3 % in the nine-month period ended July 28, 2019, differs from the U.S. statutory rate of 21.0 %, primarily due to the elimination of tax benefits in jurisdictions, including the U.S., in which it is not more likely than not that the benefit will be realized; the effects of these eliminations were partially offset by the benefits of the settlement of a tax audit, as well as a tax holiday and investment credits in certain foreign jurisdictions.
Unrecognized tax benefits related to uncertain tax positions were $1.2 million at July 28, 2019, and $1.9 million at October 31, 2018, all of which, if recognized, would favorably impact the Company’s effective tax rate. Accrued interest and penalties related to unrecognized tax benefits was $0.1
We were granted a five-year tax holiday in Taiwan which expires at the end of calendar year . This tax holiday reduced foreign taxes by $0.4 million, and $1.5 million in the three and nine-month periods ended July 28, 2019, and $1.1 and $1.8 million in the respective prior-year periods. The per-share impact of the tax holiday was a deminimus amount for the three-month period ended July 28, 2019, and per share for the nine-month periods ended July 28, 2019 and July 29, 2018, and the three-month period ended July 29, 2018.
The effective tax rates of 9.4 % and 7.8 % in the three and nine-month periods ended July 29, 2018, differ from the post U.S. Tax Reform blended statutory rate of 23.4
| • | The Act repealed the corporate alternative minimum tax (“AMT”) for tax years beginning after December 31, 2017, and provided that existing AMT credit carryforwards are fully refundable. We recognized a $ |
| • | As of January 1, 2018, the Act reduced the corporate income tax rate from a maximum |
| • | The Act imposed a transition tax for a one-time deemed repatriation of the accumulated earnings of foreign subsidiaries. The entire amount of transition tax was fully offset by tax credits (including carryforwards) that resulted in a provisional net-zero impact on the period. |
On January 18, 2018, the Taiwan Legislature Yuan approved amendments to the Income Tax Act, enacting an increase in the corporate tax rate from 17 % to 20 %, which required us to revalue our deferred tax assets and liabilities utilizing the rate applicable to the period when a temporary difference will reverse. Accordingly, a net benefit of $0.2 million is reflected in our tax provision for the period.
Adoption of New Accounting Standard
In the first quarter of 2019, the Company adopted Accounting Standards Update No. 2016-16 – “Intra-Entity Transfers Other Than Inventory”, which requires an entity to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. In connection therewith, we recorded a transition adjustment of $1.1 million that reduced prepaid income taxes (included in Other current assets on the condensed consolidated balance sheets) against beginning retained earnings.
NOTE 9 - EARNINGS PER SHARE
Three Months Ended |
Nine Months Ended |
|||||||||||||||
July 28, 2019 |
July 29, 2018 |
July 28, 2019 |
July 29 2018 |
|||||||||||||
Net income attributable to Photronics, Inc. shareholders |
$ |
$ |
$ |
$ |
||||||||||||
Effect of dilutive securities: |
||||||||||||||||
Interest expense on convertible notes, net of tax |
||||||||||||||||
Earnings used for diluted earnings per share |
$ |
$ |
$ |
$ |
||||||||||||
Weighted-average common shares computations: |
||||||||||||||||
Weighted-average common shares used for basic earnings per share |
||||||||||||||||
Effect of dilutive securities: |
||||||||||||||||
Convertible notes |
||||||||||||||||
Share-based payment awards |
||||||||||||||||
Potentially dilutive common shares |
||||||||||||||||
Weighted-average common shares used for diluted earnings per share |
||||||||||||||||
Basic earnings per share |
$ |
$ |
$ |
$ |
||||||||||||
Diluted earnings per share |
$ |
$ |
$ |
$ |
||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||
July 28, 2019 |
July 29, 2018 |
July 28, 2019 |
July 29, 2018 |
|||||||||||||
Potentially dilutive shares excluded |
||||||||||||||||
NOTE 10 - CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME BY COMPONENT
Three Months Ended July 28, 2019 |
||||||||||||
Foreign Currency Translation Adjustments |
Other |
Total |
||||||||||
Balance at April 29, 2019 |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
|||
Other comprehensive (loss) income |
( |
) |
( |
) |
||||||||
Less: other comprehensive (loss) income attributable to noncontrolling interests |
( |
) |
( |
) |
||||||||
Balance at July 28, 2019 |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
|||
Three Months Ended July 29, 2018 |
||||||||||||
Foreign Currency Translation Adjustments |
Other |
Total |
||||||||||
Balance at April 30, 2018 |
$ |
$ |
( |
) |
$ |
|||||||
Other comprehensive (loss) income |
( |
) |
( |
) |
||||||||
Less: other comprehensive (loss) income attributable to noncontrolling interests |
( |
) |
( |
) |
||||||||
Balance at July 29, 2018 |
$ |
$ |
( |
) |
$ |
|||||||
Nine Months Ended July 28, 2019 |
||||||||||||
Foreign Currency Translation Adjustments |
Other |
Total |
||||||||||
Balance at November 1, 2018 |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
|||
Other comprehensive (loss) income |
( |
) |
( |
) |
||||||||
Less: other comprehensive income attributable to noncontrolling interests |
||||||||||||
Balance at July 28, 2019 |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
|||
Nine Months Ended July 29, 2018 |
||||||||||||||||
Foreign Currency Translation Adjustments |
Amortization of Cash Flow Hedge |
Other |
Total |
|||||||||||||
Balance at October 30, 2017 |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
||||||||
Other comprehensive (loss) income before Reclassifications |
( |
) |
( |
) |
||||||||||||
Amounts reclassified from accumulated other comprehensive income |
||||||||||||||||
Net current period other comprehensive (loss) income |
( |
) |
( |
) |
||||||||||||
Less: other comprehensive (loss) income attributable to noncontrolling interests |
( |
) |
( |
) |
||||||||||||
Balance at July 29, 2018 |
$ |
$ |
$ |
( |
) |
$ |
||||||||||
NOTE 11 - FAIR VALUE MEASUREMENTS
The accounting framework for determining fair value includes a hierarchy for ranking the quality and reliability of the information used to measure fair value, which enables the reader of the financial statements to assess the inputs used to develop those measurements. The fair value hierarchy consists of three tiers as follows: Level 1, defined as quoted market prices (unadjusted) in active markets for identical securities; Level 2, defined as inputs other than Level 1 that are observable, either directly or indirectly; and Level 3, defined as unobservable inputs that are not corroborated by market data.
The fair values of our cash and cash equivalents (Level 1 measurements), accounts receivable, accounts payable, and certain other current assets and current liabilities (Level 2 measurements) approximate their carrying values due to their short-term maturities. The fair values of our variable rate debt instruments is a Level 2 measurement and approximates their carrying values due to the variable nature of the underlying interest rates. The fair values of our convertible senior notes is a Level 2 measurement, as it was determined using inputs that were either observable market data, or could be derived from, or corroborated with, observable market data. These inputs included our stock price and interest rates offered on debt issued by entities with credit ratings similar to ours. We did no
Fair Value of Financial Instruments Not Measured at Fair Value
The fair value of our convertible senior notes was a Level 2 measurement, as it was determined using inputs that were either observable market data or could be derived from, or corroborated with, observable market data. These inputs included our stock price and interest rates offered on debt issued by entities with credit ratings similar to ours. The table below presents the fair and carrying values of our convertible senior notes at October 31, 2018.
October 31, 2018 |
||||||||
Fair Value |
Carrying Value |
|||||||
$ |
$ |
|||||||
NOTE 12 – SHARE REPURCHASE PROGRAM
Nine Months Ended July 28, 2019 |
From Inception Date of October 22, 2018 |
|||||||
Number of shares repurchased |
||||||||
Cost of shares repurchased |
$ |
$ |
||||||
Average price paid per share |
$ |
$ |
||||||
In August 2019, the Company’s board of directors authorized the repurchase of up to $100 million of its common stock, to be executed in accordance with a repurchase plan under rule 10b5-1 of the Securities Act of 1933 (as amended). The authorization does not obligate the Company to repurchase any dollar amount or number of shares of common stock, and the repurchase program may be suspended or discontinued at any time.
NOTE 13 - COMMITMENTS AND CONTINGENCIES
As of July 28, 2019, the Company had commitments outstanding for capital expenditures of approximately $100 million, nearly all of which related to building and equipping our China facilities.
We are subject to various claims that arise in the ordinary course of business. We believe that such claims, individually or in the aggregate, will not have a material effect on the consolidated financial statements.
NOTE 14 - RECENT ACCOUNTING PRONOUNCEMENTS
In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-13 “Measurement of Credit Losses”, the main objective of which is to provide more useful information about expected credit losses on financial instruments and other commitments of an entity to extend credit. In support of this objective, the ASU replaces the incurred loss model, found in current GAAP, with an expected credit loss model; the new model requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. This ASU requires a cumulative-effect adjustment as of the beginning of the first reporting period in which the guidance is adopted. ASU 2016-13 is effective for Photronics, Inc. in its first quarter of fiscal year 2021, with early adoption permitted. We are currently evaluating the effect that this ASU will have on our consolidated financial statements.
In February 2016, the FASB issued ASU 2016-02 “Leases (Topic 842)”, which requires lessees to recognize right-of-use assets and corresponding liabilities for all leases with an initial term in excess of twelve months. ASU 2016-02 was to be adopted using a modified retrospective approach, that requires leases to be measured and recognized under the new guidance at the beginning of the earliest period presented. In July 2018, the FASB issued ASU 2018-11 “Leases (Topic 842) – Targeted Improvements” (“ASU 2018-11”), which provided entities with an additional (and optional) transition method to adopt the new leases standard. Under this optional transition method, an entity initially applies the new leases standard at its adoption date and recognizes the effects of adoption through cumulative-effect adjustments to its beginning balance sheet. We will utilize this optional method when we transition to the new leases guidance and, as a result, expect to recognize significant amounts of right-of-use assets and lease liabilities in our fiscal year 2020 beginning balance sheet. ASU 2016-02 included a number of practical expedients, which we are currently in the process of evaluating, that entities can elect to use as they transition to the new guidance. To date, an implementation team has been established to evaluate our lease portfolio, system process and policy change requirements. The Company has made progress in drafting new lease accounting policies, and is gathering the necessary data elements for the lease population.
Accounting Standards Updates Implemented
In November 2016, the FASB issued ASU 2016-18 “Restricted Cash”, which requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. ASU 2016-18 was effective for Photronics, Inc. in its first quarter of fiscal year 2019 and was applied on a retrospective transition basis. Our adoption of this Update did not materially impact our cash flows statement.
In October 2016, the FASB issued ASU 2016-16 “Intra-Entity Transfers of Assets Other Than Inventory”, which eliminates the exception of recognizing, at the time of transfer, current and deferred income taxes for intra-entity asset transfers other than inventory. ASU 2016-16 was effective for us in our first quarter of fiscal year 2019 and applied on a modified retrospective transition basis. Please see Note 8 for a discussion of the effects of adopting this guidance.
In May 2014, the FASB issued ASU 2014-09 “Revenue from Contracts with Customers”, which superseded nearly all then existing revenue recognition guidance under accounting principles generally accepted in the United States. The core principle of this ASU is that revenue should be recognized for the amount of consideration expected to be received for promised goods or services transferred to customers. This ASU also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments, and assets recognized for costs incurred to obtain or fulfill a contract. In August 2015, the FASB issued ASU 2015-14 which deferred the effective date of ASU 2014-09 by one year and allowed entities to early adopt, but no earlier than the original effective date. This update allowed for either full retrospective or modified retrospective adoption. In April 2016, the FASB issued ASU 2016-10 “Identifying Performance Obligations and Licensing” which amended guidance previously issued on these matters in ASU 2014-09. The effective date and transition requirements of ASU 2016-10 were the same as those for ASU 2014-09.
We adopted the new revenue and related guidance on November 1, 2018, using the modified retrospective approach, under which we increased our accounts receivable by $0.6 million, recognized contract assets of $4.6 million, reduced our inventories balance by $3.7 million, and recorded an accrual for income taxes of $0.3 million. The recognition of, and adjustments to, these items were reflected in increases to our retained earnings and noncontrolling interest balances of $1.1 million and $0.1 million, respectively. The most significant impact of the new guidance on our financial statements is its requirement for us to recognize revenue as we manufacture products for which, in the event that the customer cancels the contract, we are entitled to reasonable compensation for work we have completed prior to cancellation. Prior to our adoption of Topic 606, we recognized revenue when we shipped to customers or, under some arrangements, when the customers received the goods. The impact of the adoption of this guidance on our July 28, 2019, financial statements is presented in Note 6.
The guidance allows for a number of accounting policy elections and practical expedients. In addition to our above-mentioned election to use the modified retrospective application method for adopting the guidance, those we have employed that are most significant to us are summarized below.
Shipping and handling activities performed after control of a good is transferred to a customer
We have elected to treat shipping and handling activities that occur after control of a good is transferred to a customer as activities to fulfill our promise to transfer goods to the customer. Thus, such activities will not be considered to be separate performance obligations under contracts with our customers.
Non-recognition of financing component when we transfer goods to a customer and the period between when we transfer and when we are paid will be less than one year
We have elected the practical expedient that allows for the non-recognition, as a component of a customer contract, of a financing component when the period between when we transfer a good and when we are paid will be less than one year.
Exclusion of sales and similar taxes collected from customers in the transaction price
Consistent with our practice before adoption of the new guidance, we will not recognize sales and similar taxes we collect from customers as revenue.
Use of an “input method” to measure our progress towards the transfer of control of performance obligations to customers
As, in our judgment, an input method based on our efforts to satisfy our performance obligations will best serve to depict the transfer of control of our performance obligations to our customers, we have adopted an accounting policy to employ such a method. Our decision was based primarily on the facts that our photomasks are not physically transferred to customers until they are complete, and that we can employ our input-based cost accumulation systems and methods to measure our progress towards the transfer of control of our performance obligations to customers.
Non-disclosure of the transaction prices of unsatisfied or partially satisfied performance obligations
For contracts that have an original expected duration of one year or less, we have elected the practical expedient that allows us not to disclose the aggregate transaction prices of unsatisfied or partially satisfied performance obligations that exist at the end of a reporting period.
Overview
Management's discussion and analysis ("MD&A") of the Company's financial condition, results of operations and outlook should be read in conjunction with its condensed consolidated financial statements and related notes. Various segments of this MD&A contain forward-looking statements, all of which are presented based on current expectations, which may be adversely affected by uncertainties and risk factors (presented throughout this filing and in the Company's Annual Report on Form 10-K for the fiscal 2018 year), that may cause actual results to materially differ from these expectations.
We sell substantially all of our photomasks to semiconductor and FPD designers and manufacturers. Photomask technology is also being applied to the fabrication of other higher-performance electronic products such as photonics, microelectronic mechanical systems and certain nanotechnology applications. Our selling cycle is tightly interwoven with the development and release of new semiconductor and FPD designs and applications, particularly as they relate to the microelectronic industry's migration to more advanced product innovation, design methodologies and fabrication processes. We believe that the demand for photomasks primarily depends on design activity rather than sales volumes from products manufactured using photomask technologies. Consequently, an increase in semiconductor or FPD sales does not necessarily result in a corresponding increase in photomask sales. However, the reduced use of customized ICs, reductions in design complexity, other changes in the technology or methods of manufacturing or designing semiconductors, or a slowdown in the introduction of new semiconductor or FPD designs could reduce demand for photomasks ‒ even if the demand for semiconductors and FPDs increases. Advances in semiconductor, FPD, and photomask design and semiconductor and FPD production methods that shift the burden of achieving device performance away from lithography could also reduce the demand for photomasks. Historically, the microelectronic industry has been volatile, experiencing periodic downturns and slowdowns in design activity. These downturns have been characterized by, among other things, diminished product demand, excess production capacity, and accelerated erosion of selling prices, with a concomitant effect on revenue and profitability.
We are typically required to fulfill customer orders within a short period of time after receipt of an order, sometimes within twenty-four hours. This results in a minimal level of backlog orders, typically one to two weeks of backlog for IC photomasks and two to three weeks of backlog for FPD photomasks.
The global semiconductor and FPD industries are driven by end markets which have been closely tied to consumer-driven applications of high-performance devices, including, but not limited to, mobile display devices, mobile communications, and computing solutions. While we cannot predict the timing of the industry's transition to volume production of next-generation technology nodes, or the timing of up and down cycles with precise accuracy, we believe that such transitions and cycles will continue into the future, beneficially and adversely affecting our business, financial condition, and operating results as they occur. We believe our ability to remain successful in these environments is dependent upon the achievement of our goals of being a service and technology leader and efficient solutions supplier, which we believe should enable us to continually reinvest in our global infrastructure.
In the fourth quarter of fiscal 2019, the Company’s board of directors authorized the repurchase of up to $100 million of its common stock, to be executed in accordance with a repurchase plan under rule 10b5-1 of the Securities Act of 1933 (as amended). The authorization does not obligate the Company to repurchase any dollar amount or number of shares of common stock, and the repurchase program may be suspended or discontinued at any time.
Effective the third quarter of fiscal 2019, the Company entered into a Master Lease Agreement (“MLA”) which enables us to request advance payments or other funds for equipment or enter into an equipment lease in the U.S. In connection with this MLA, we were approved for financing of $35 million for the purchase of equipment; as of July 28, 2019, we had no outstanding borrowings against this MLA. In the fourth quarter of fiscal 2019, the financing entity, upon our request, made an advance payment of $3.4 million to an equipment vendor on our behalf. Interest on this borrowing is payable monthly at thirty-day LIBOR plus 1%, and will continue to accrue until the borrowing is repaid or, as allowed under the MLA, we enter into a lease for the equipment. All borrowings under the MLA are secured by the equipment purchased or financed.
In the second quarter of fiscal 2019, we repaid, upon maturity, the entire $57.5 million principal amount of the convertible senior notes we issued in April 2016.
In the second quarter of fiscal 2019, PDMC, the Company’s majority-owned IC subsidiary in Taiwan, declared a dividend of which 49.99%, or approximately $18.8 million, will be paid to noncontrolling interests in the fourth quarter of fiscal 2019.
In the first quarter of fiscal 2019, PDMC paid a dividend, of which 49.99%, or approximately $26.1 million, was paid to noncontrolling interests.
In the first quarter of fiscal 2019, PDMCX was approved for credit of $50 million, subject to certain limitations related to PDMCX registered capital at the time of the initial approval, pursuant to which PDMCX has and will enter into separate loan agreements (“the Project Loans”) for intermittent borrowings. The Project Loans, which are denominated in Chinese renminbi (RMB), are being used to finance certain capital expenditures in China. PDMCX granted liens on its land, building, and certain equipment as collateral for the Project Loans. As of July 28, 2019, PDMCX had borrowed 243.4 million RMB ($35.4 million) against this approval, which includes $9.6 million borrowed during the three-month period ended July 28, 2019. See Note 5 of the condensed consolidated financial statements for additional information on these loans.
In the first quarter of fiscal 2019, PDMCX received approval for unsecured credit of $25.0 million, pursuant to which PDMCX may enter into separate loan agreements. Under this credit agreement (the “Working Capital Loan”), PDMCX can borrow up to 140.0 million RMB, or approximately $20.4 million, to pay value-added taxes (“VAT”) and up to 60.0 million RMB ($8.7 million) to fund operations; combined total borrowings are limited to $25.0 million. During the quarter ended July 28, 2019, PDMCX borrowed 11.4 million RMB ($3.9 million) to fund operations, with repayments due one year from their borrowing dates. Through July 28, 2019, PDMCX borrowed 68.0 million RMB ($9.9 million) to pay VAT, and repaid $0.1 million as of that date. Payments on these borrowings are due semiannually, at an increasing rate, through January 2022. See Note 5 of the condensed consolidated financial statements for additional information on these loans.
In the fourth quarter of fiscal 2018, we entered into a five year amended and restated credit agreement (“the credit agreement”), which has a $50 million borrowing limit, with an expansion capacity to $100 million. The credit agreement is secured by substantially all of our assets located in the United States and common stock we own in certain foreign subsidiaries. The credit agreement includes minimum interest coverage ratio, total leverage ratio, and minimum unrestricted cash balance covenants (all of which we were in compliance with at July 28, 2019), and limits the amount of dividends, distributions, and redemptions we can pay on our stock to an aggregate amount of $100 million. We had no outstanding borrowings against the credit agreement at July 28, 2019, and $50 million was available for borrowing. The interest rate on the credit agreement (2.5% at July 28, 2019) is based on our total leverage ratio at LIBOR plus a spread, as defined in the credit agreement.
In the fourth quarter of fiscal 2018, the Company’s board of directors authorized the repurchase of up to $25 million of its common stock, to have been executed in open-market transactions or in accordance with a repurchase plan under rule 10b5-1 of the Securities Act of 1933 (as amended). The share repurchase program commenced, under rule 10b5-1, on October 22, 2018, and expired on February 1, 2019. In total, we repurchased 1.5 million shares at a cost of $13.8 million (an average of $9.41 per share) under this program.
In the third quarter of fiscal 2018, the Company’s board of directors authorized the repurchase of up to $20 million of its common stock, which was effectuated in open-market transactions or in accordance with a repurchase plan under rule 10b5-1 of the Securities Act of 1933 (as amended). The share repurchase program commenced on July 10, 2018, and ended in October 2018. In total, under this program, we repurchased 2.2 million shares at a cost of $20 million (an average of $8.97 per share).
In the first quarter of fiscal 2018, we announced the successful closing of the China joint venture agreement with Dai Nippon Printing Co., Ltd. (“DNP”), which we had agreed to enter into and announced in the third quarter of fiscal 2017. Under the agreement, our wholly owned Singapore subsidiary owns 50.01% of the joint venture, which is named Xiamen American Japan Photronics Mask Co., Ltd. (PDMCX), and a subsidiary of DNP owns the remaining 49.99%. The financial results of the joint venture are included in the Photronics, Inc. consolidated financial statements. See Note 4 of the condensed consolidated financial statements for additional information on the joint venture.
In the fourth quarter of fiscal 2017, we announced that Photronics UK, Ltd., a wholly owned subsidiary of ours, signed an investment agreement with Hefei State Hi-tech Industry Development Zone to establish a manufacturing facility in Hefei, China. Under the terms of the agreement, through our subsidiary, we agreed to invest a minimum of $160 million to build and operate a research and development and manufacturing facility for high-end and mainstream FPD photomasks. As of April 28, 2019, we had met the minimum investment requirement and satisfied the terms of the agreement. Hefei State Hi-tech Industry Development Zone is providing certain investment incentives and support for this facility, which has the capability to produce up to G10.5+ large area masks and AMOLED products. Construction of this facility was completed in late 2018, and production commenced in the second quarter of 2019.
Material Changes in Results of Operations
Three and Nine Months ended July 28, 2019
The following table presents selected operating information expressed as a percentage of revenue.
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||
July 28, 2019 |
April 28, 2019 |
July 29, 2018 |
July 28, 2019 |
July 29, 2018 |
||||||||||||||||
Revenue |
100.0 |
% |
100.0 |
% |
100.0 |
% |
100.0 |
% |
100.0 |
% |
||||||||||
Cost of goods sold |
77.9 |
80.2 |
73.9 |
79.0 |
75.4 |
|||||||||||||||
Gross profit |
22.1 |
19.8 |
26.1 |
21.0 |
24.6 |
|||||||||||||||
Selling, general and administrative expenses |
9.5 |
10.1 |
9.2 |
10.2 |
9.7 |
|||||||||||||||
Research and development expenses |
2.9 |
2.7 |
1.9 |
3.0 |
2.7 |
|||||||||||||||
Operating income |
9.7 |
7.0 |
15.0 |
7.8 |
12.2 |
|||||||||||||||
Other (expense) income, net |
(0.2 |
) |
3.0 |
1.0 |
1.2 |
0.2 |
||||||||||||||
Income before income taxes |
9.5 |
10.0 |
16.0 |
9.0 |
12.4 |
|||||||||||||||
Income tax provision |
2.4 |
2.5 |
1.5 |
2.0 |
1.0 |
|||||||||||||||
Net income |
7.1 |
7.5 |
14.5 |
7.0 |
11.4 |
|||||||||||||||
Net income attributable to noncontrolling interests |
2.5 |
1.1 |
5.0 |
1.9 |
3.8 |
|||||||||||||||
Net income attributable to Photronics, Inc. shareholders |
4.6 |
% |
6.4 |
% |
9.5 |
% |
5.1 |
% |
7.6 |
% |
||||||||||
Note: All of the following tabular comparisons, unless otherwise indicated, are for the three months ended July 28, 2019 (Q3 FY19), April 28, 2019 (Q2 FY19) and July 29, 2018 (Q3 FY18), and for the nine months ended July 28, 2019 (YTD FY19) and July 29, 2018 (YTD FY18), in millions of dollars.
Revenue
The following tables present revenue changes by product type and geographic areas. Columns may not total due to rounding.
Q3 FY19 from Q2 FY19 |
Q3 FY19 from Q3 FY18 |
YTD FY19 from YTD FY18 |
||||||||||||||||||||||||||||||
Revenue in Q3 FY19 |
Increase (Decrease) |
Percent Change |
Increase (Decrease) |
Percent Change |
Revenue in YTD FY19 |
Increase (Decrease) |
Percent Change |
|||||||||||||||||||||||||
IC |
||||||||||||||||||||||||||||||||
High-end |
$ |
38.5 |
$ |
0.0 |
0.1 |
% |
$ |
(7.6 |
) |
(16.5 |
)% |
$ |
111.5 |
$ |
(9.5 |
) |
(7.8 |
)% |
||||||||||||||
Mainstream |
61.7 |
1.6 |
2.6 |
% |
0.6 |
0.9 |
% |
182.2 |
(2.1 |
) |
(1.1 |
)% |
||||||||||||||||||||
Total IC |
$ |
100.2 |
$ |
1.6 |
1.6 |
% |
$ |
(7.1 |
) |
(6.6 |
)% |
$ |
293.7 |
$ |
(11.5 |
) |
(3.8 |
)% |
||||||||||||||
FPD |
||||||||||||||||||||||||||||||||
High-end |
$ |
25.9 |
$ |
3.0 |
13.0 |
% |
$ |
8.9 |
52.0 |
% |
$ |
70.4 |
$ |
16.3 |
30.1 |
% |
||||||||||||||||
Mainstream |
12.0 |
2.0 |
19.4 |
% |
(0.1 |
) |
(0.7 |
)% |
30.4 |
(1.0 |
) |
(3.0 |
)% |
|||||||||||||||||||
Total FPD |
$ |
37.9 |
$ |
4.9 |
15.0 |
% |
$ |
8.8 |
30.1 |
% |
$ |
100.8 |
$ |
15.3 |
17.9 |
% |
||||||||||||||||
Total Revenue |
$ |
138.1 |
$ |
6.5 |
5.0 |
% |
$ |
1.7 |
1.3 |
% |
$ |
394.4 |
$ |
3.8 |
1.0 |
% |
||||||||||||||||
Q3 FY19 from Q2 FY19 |
Q3 FY19 from Q3 FY18 |
YTD FY19 from YTD FY18 |
||||||||||||||||||||||||||||||
Revenue in Q3 FY19 |
Increase (Decrease) |
Percent Change |
Increase (Decrease) |
Percent Change |
Revenue in YTD FY19 |
Increase (Decrease) |
Percent Change |
|||||||||||||||||||||||||
Taiwan |
$ |
61.3 |
$ |
4.8 |
8.5 |
% |
$ |
(0.8 |
) |
(1.3 |
)% |
$ |
175.5 |
$ |
0.7 |
0.4 |
% |
|||||||||||||||
Korea |
37.1 |
(0.9 |
) |
(2.4 |
)% |
(0.1 |
) |
(0.3 |
)% |
110.4 |
4.1 |
3.8 |
% |
|||||||||||||||||||
United States |
25.4 |
(1.4 |
) |
(5.2 |
)% |
(2.4 |
) |
(8.5 |
)% |
74.6 |
(7.4 |
) |
(9.0 |
)% |
||||||||||||||||||
Europe |
7.9 |
(0.5 |
) |
(5.9 |
)% |
(0.6 |
) |
(7.0 |
)% |
24.7 |
(1.0 |
) |
(4.0 |
)% |
||||||||||||||||||
China |
6.0 |
4.5 |
306.4 |
% |
5.7 |
2,225.3 |
% |
7.7 |
7.2 |
1,363.0 |
% |
|||||||||||||||||||||
Other |
0.5 |
0.0 |
6.2 |
% |
(0.1 |
) |
(17.4 |
)% |
1.5 |
0.2 |
14.5 |
% |
||||||||||||||||||||
$ |
138.1 |
$ |
6.5 |
5.0 |
% |
$ |
1.7 |
1.3 |
% |
$ |
394.4 |
$ |
3.8 |
1.0 |
% |
|||||||||||||||||
Our quarterly revenues can be affected by the seasonal purchasing tendencies of our customers. As a result, demand for our products is typically negatively impacted during the first, and sometimes the second, quarters of our fiscal year, by the North American, European, and Asian holiday periods, as some of our customers reduce their development and, consequently, their buying activities during those periods. High-end photomask applications include mask sets for 28 nanometer and smaller products for IC, and G8 and above and active matrix organic light-emitting diode (AMOLED) display technologies for FPD products. High-end photomasks typically have higher selling prices (ASPs) than mainstream products.
Revenue increased 5.0% in Q3 FY19, compared with Q2 FY19, as a result of overall FPD and IC growth. FPD revenue increased 15% due to increased demand for AMOLED products, as our customers in Korea and China continued to release new designs, and we benefited from an increase in capacity as we ramp production in China, including for G10.5+ photomasks. IC revenue increased 1.6% due to increased demand from Asian foundries for mainstream nodes.
Revenue increased 1.3% in Q3 FY19, compared with Q3 FY18, as increased FPD revenues offset a decline in IC. FPD revenues increased 30.1% primarily due to significantly increased demand for AMOLED products. We also ramped production of G10.5+ photomasks at our new facility in China. IC revenue decreased 6.6% from the prior year quarter, due in part to the geopolitical conditions in Asia tempering growth in that region.
Revenue increased 1.0% in YTD FY19, compared with YTD FY18, as increased demand for AMOLED products offset a moderate decline in IC demand and a more substantial decrease in demand for other high-end FPD products (excluding G10.5+ masks). Demand for IC was notably strong from both foundries and customers with captive mask shops in YTD FY18.
Looking forward, we expect demand for both AMOLED and large format FPD masks (i.e. G10.5+) to increase, as more panel fabrication facilities begin production and new design releases occur at both new and existing facilities. High-end IC is expected to be stable to improving, but growth may be temporarily forestalled in Asia due to the effects of the current state of U.S. – China trade relations, as well as rising tensions between Japan and Korea, which may present supply-chain challenges for some of our customers. Despite these issues, we believe that the IC and FPD markets in Asia represent long-term growth opportunities.
Gross Margin
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||||||||||
Q3 FY19 |
Q2 FY19 |
Percent Change |
Q3 FY18 |
Percent Change |
YTD FY19 |
YTD FY18 |
Percent Change |
|||||||||||||||||||||||||
Gross profit |
$ |
30.6 |
$ |
26.0 |
17.5 |
% |
$ |
35.6 |
(14.1 |
)% |
$ |
82.7 |
$ |
96.1 |
(13.9 |
)% |
||||||||||||||||
Gross margin |
22.1 |
% |
19.8 |
% |
26.1 |
% |
21.0 |
% |
24.6 |
% |
||||||||||||||||||||||
Gross margin increased 2.3% from Q2 FY19, primarily as a result of the $6.5 million increase in revenue discussed above. Reduced compensation and related expenses of $0.3 million, and an increase of $0.6 million of overhead costs transferred to research and development expense, also favorably impacted gross margin. Somewhat offsetting these favorable impacts, depreciation expense increased $2.2 million in Q3 FY19, as we recognized a full quarter of depreciation for assets placed in service at our China FPD plant and commenced depreciation on a significant number of assets at our China IC plant. In addition, equipment costs, primarily related to tool relocations to our China facilities, increased $0.6 million from the prior quarter. On a consolidated basis, material costs, as a percentage of revenue, sequentially increased 1.7%, primarily due to changes in product mix.
Gross margin decreased 4.0% in Q3 FY19 from Q3 FY18, despite a 1.3% increase in revenue from the prior year quarter. The decrease was, in significant part, due to increased losses at our two China facilities of $6.3 million, both of which recently commenced manufacturing operations. The increased losses at the China facilities were, to a great degree, caused by increased depreciation expense of $2.8 million, as depreciation commenced on equipment when it achieved customer qualification, which precedes revenue generation. Compensation and related expenses at the China facilities increased by $0.9 million from the prior year quarter, reflecting the increased staffing required for qualification and production.
On a year-to-date basis, gross margin decreased 3.6%, with increased losses totaling $9.8 million at our two China-based facilities constituting the most significant causes; our FPD facility in China commenced production late in Q2 FY19, and our IC facility commenced production in Q3 FY19.
Selling, General and Administrative Expenses
Selling, general and administrative expenses decreased $0.1 million, or 1.1%, to $13.1 million in Q3 FY19, from $13.3 million in Q2 FY19, primarily due to decreased general and administrative expenses of $0.3 million, partially offset by increased selling expenses in China. Selling, general and administrative expenses increased in Q3 FY19 $0.6 million, or 5.0%, to $13.1 million from $12.5 million in Q3 FY18. Selling general and administrative expenses incurred in China increased $0.7 million from the prior year quarter, reflecting the completion of construction and commencement of operations at our two China facilities. On a year-to-date basis, selling, general and administrative expenses increased $2.3 million, or 6.1%, to $40.2 million from $37.9 million. Expenses related to our expansion into China accounted for $2.0 million of this increase; increased compensation and related expenses at other sites comprised an additional $0.2 million of the total increase.
Research and Development Expenses
Research and development expenses consist of development efforts related to high-end process technologies for 28nm and smaller IC nodes. In Asia, in addition to the focus on high-end IC process technology nodes, G8 and above FPDs and AMOLED applications are also under development.
Research and development expenses increased $0.5 million, or 14.2%, from Q2 FY19, reflecting an increase in IC related qualification activities somewhat offset by decreased qualification activities in FPD (except China). Research and development expenses increased $1.4 million in Q3 FY19, or 52.5% from Q3 FY18; increased IC related qualification activities accounted for the preponderance of the change, with most of the remainder being attributable to qualification activities at our China FPD facility. On a year-to-date basis, research and development expenses increased $1.3 million, or 12.1%, as qualification related expenses increased for both IC and FPD products.
Other Income (Expense), net
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||
Q3 FY19 |
Q2 FY19 |
Q3 FY18 |
YTD FY19 |
YTD FY18 |
||||||||||||||||
Interest income and other income (expense), net |
$ |
- |
$ |
4.3 |
$ |
2.0 |
$ |
6.0 |
$ |
2.3 |
||||||||||
Interest expense |
(0.4 |
) |
(0.4 |
) |
(0.6 |
) |
(1.3 |
) |
(1.7 |
) |
||||||||||
Other income (expense), net |
$ |
(0.4 |
) |
$ |
3.9 |
$ |
1.4 |
$ |
4.7 |
$ |
0.6 |
|||||||||
Interest income and other income (expense), net decreased from Q2 FY19 by $4.3 million, primarily due to a $4.0 million negative change in foreign currency exchange results. Interest income and other income (expense), net decreased from Q3 FY18 by $2.0 million, primarily because of a $1.2 million negative change in foreign currency exchange results and decreased interest income of $0.4 million, which was due to our lower average cash balance in the current year period. On a year-to-date basis, Interest income and other income (expense), net, increased $3.7 million, primarily because of the impact of $6.2 million from foreign currency exchange gains in YTD FY19, in contrast to losses incurred in YTD FY18. The effect of the foreign exchange gains was somewhat offset by government incentives of $0.8 million received, a $0.6 million gain on the sale of certain assets recognized in YTD FY18, and reduced interest income of $1.1 million, due to the lower average cash balance in the current year period.
Interest expense was $0.4 million in Q3 FY19, unchanged from Q2 FY19. Interest expense decreased $0.2 million in Q3 FY19 from Q3 FY18, and $0.4 million in YTD FY19 from YTD FY18, primarily due to the repayment of our $57.5 million convertible senior notes in April 2019; interest incurred on our loans in China partially offset these reductions.
Income Tax Provision
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||
Q3 FY19 |
Q2 FY19 |
Q3 FY18 |
YTD FY19 |
YTD FY18 |
||||||||||||||||
Income tax provision |
$ |
3.2 |
$ |
3.3 |
$ |
2.1 |
$ |
7.9 |
$ |
3.8 |
||||||||||
Effective income tax rate |
24.7 |
% |
25.0 |
% |
9.4 |
% |
22.3 |
% |
7.8 |
% |
||||||||||
The effective income tax rate is sensitive to the jurisdictional mix of earnings, due, in part, to the non-recognition of tax benefits on losses in jurisdictions with valuation allowances.
The effective income tax rate decreased in Q3 FY19, compared with Q2 FY19, primarily due to changes in the jurisdictional mix of earnings. The effective income tax rate increased in Q3 FY19, compared with Q3 FY18, due to changes in the jurisdictional mix of earnings and nonrecurring tax benefits related to a settlement with a taxing authority and a statute of limitations expiration in Q3 FY18.
The effective income tax rate increased in YTD FY19, compared with YTD FY18, primarily due to our recognition in YTD FY18 of nonrecurring tax benefits related to tax reform in the U.S. and Taiwan of $4.2 million, and a one-time audit settlement benefit of $1.9 million. The year-over-year increase in the effective tax rate was somewhat tempered by a one-time audit settlement benefit of $0.9 million in YTD FY19, as well as changes in the jurisdictional mix of earnings.
Net Income Attributable to Noncontrolling Interests
Net income attributable to noncontrolling interests was $3.5 million in Q3 FY19, which represented an increase of $2.1 million and a decrease $3.3 million from Q2 FY19 and Q3 FY18, respectively. Year-to-date, noncontrolling interests’ share decreased $7.5 million from YTD FY18. The changes for all comparative periods were due to changes in net income at our IC manufacturing facilities in Taiwan and China, in which noncontrolling interests hold 49.99% ownership interests.
Liquidity and Capital Resources
Our working capital at the end of Q3 FY19 was $261.2 million, compared with $311.7 million at the end of fiscal 2018. The $50.5 million net decrease is primarily attributable to:
- Decreased cash and cash equivalents of $74.5 million (net of $57.5 million used to repay our convertible senior notes, which had no impact on working capital);
- Increased inventories of $10.8 million, the predominance of which was to supply our China FPD facility and,
- Receivables for investment subsidies in China of $11.9 million at the end of Q3 FY19.
We had cash and cash equivalents of $197.2 million at the end of Q3 FY19, compared with $329.3 million at the end of fiscal 2018. The net decrease is primarily attributable to:
- $57.5 million used to repay our convertible notes;
- $160.1 million used to purchase capital assets (the preponderance of which related to equipping our China-based facilities);
- $10.7 million used to repurchase our common stock;
- $53.2 million received from borrowings in China;
- $17.7 million received from investment incentives in China and,
- $23.5 million provided by operating activities.
The net cash provided by operating activities of $23.5 million in YTD FY19 decreased $63.5 million, from $87.0 million provided in YTD FY18. The net decrease was due primarily to:
- Lower net income of $17.0 million in YTD FY19;
- A greater increase in the change in inventories balances of $6.7 million in YTD FY19 (primarily attributable to the stocking of our FPD facility in China) and,
- A comparative increase in value added tax prepayments related to our China facilities of $24.3 million in YTD FY19. These prepayments are recoverable through future sales transactions of the facilities.
The favorable effects of foreign currency exchange rates contributed $1.2 million to our reported cash balance at July 28, 2019.
Net cash used in investing activities was $142.5 million in YTD FY19, an increase of $78.4 million from the $64.1 million used in YTD FY18. The net increase was primarily attributable to increased capital expenditures of $95.8 million, the predominance of which related to the building and equipping of our China facilities. Partially offsetting the increased capital expenditures was $17.7 million received in China from investment incentives.
Net cash flows from financing activities decreased from funds provided of $2.6 million in YTD FY18 to $14.3 million of funds used in YTD FY19. Significant components of the net decrease were:
- $57.5 million used to repay (upon their maturity) our convertible senior notes;
- $26.1 million used to pay dividends to DNP (related to their 49.99% interest in our IC facility in Taiwan);
- $10.7 million used to acquire our common stock under a share repurchase program;
- $53.2 million received from borrowings in China and,
- $29.4 million contributed by DNP for their investment in our recently established IC joint venture in China.
As of July 28, 2019, and October 31, 2018, our total cash and cash equivalents included $153.9 million and $244.5 million, respectively, held by our foreign subsidiaries. The majority of earnings of our foreign subsidiaries are considered to be indefinitely reinvested. Repatriation of these funds to the U.S. may subject them to U.S. state income taxes and local country withholding taxes in certain jurisdictions. Furthermore, our foreign subsidiaries continue to grow through the reinvestment of earnings in additional manufacturing capacity and capability, particularly in the high-end IC and FPD areas.
As of July 28, 2019, we had capital commitments outstanding of approximately $100 million, much of which related to building and equipping our China facilities (discussed below). We intend to finance our capital expenditures with our working capital, cash generated from operations and, if necessary, additional borrowings. We entered into a joint venture that constructed an IC facility in China with an estimated total joint investment of $160 million. Our remaining funding commitment for the joint venture is approximately $7 million which we will fulfill over the next several quarters. In Q2 FY19, we commenced production at our newly constructed FPD facility in China in which, as of July 28, 2019, we had invested $160 million. We believe that our cash on hand, cash generated from operations and amounts available to borrow will be sufficient to meet our cash requirements for the next twelve months. We regularly review the availability and terms at which we might issue additional equity or debt securities in the public or private markets. However, we cannot assure that additional sources of financing would be available to us on commercially favorable terms, should our requirements exceed our existing cash, cash generated by operations, and cash available under our credit agreement.
Our liquidity, as we operate in a high fixed cost environment, is highly dependent on our revenue, cash conversion cycle, and the timing of our capital expenditures (which can vary significantly from period to period). Depending on conditions in the semiconductor and FPD markets, our cash flows from operations and current holdings of cash may not be adequate to meet our current and long-term needs for capital expenditures, operations, and debt repayments. Historically, in certain years, we have used external financing to fund these needs. Due to conditions in the credit markets and covenant restrictions on our existing debt, some financing instruments we have used in the past may not be available to us when required. Consequently, we cannot assure that additional sources of financing would be available to us on commercially favorable terms, should our long-term cash requirements exceed our existing cash and cash available under our credit agreements.
Off-Balance Sheet Arrangements
In January 2018, Photronics, through its wholly owned Singapore subsidiary, and DNP, through its wholly owned subsidiary “DNP Asia Pacific PTE, Ltd.” entered into a joint venture under which DNP obtained a 49.99% interest in our IC business in Xiamen, China. The joint venture, known as “Photronics DNP Mask Corporation Xiamen” (“PDMCX”), was established to develop and manufacture photomasks for leading-edge and advanced-generation semiconductors. Under the Joint Venture Operating Agreement of PDMCX (“the Agreement”), DNP is afforded, under certain circumstances, the right to “put” its interest in PDMCX to Photronics. These circumstances include disputes regarding the strategic direction of PDMCX that may arise after the initial two-year term of the Agreement that cannot be resolved between the two parties. In addition, both Photronics and DNP have the option to purchase, or put, their interest from, or to, the other party, should their ownership interest fall below 20% for a period of more than six consecutive months. Under all such circumstances, the sales of ownership interests would be at the exiting party’s ownership percentage of the joint venture’s net book value, with closing to take place within three business days of obtaining required approvals and clearance. Should DNP exercise an option to put their, or purchase our, interest in PDMCX we may, depending on the relationship of the fair and book value of PDMCX’s net assets, incur a loss. As of July 28, 2019, Photronics and DNP each had net investments in PDMCX of approximately $42.5 million.
We lease certain office facilities and equipment under operating leases that may require us to pay taxes, insurance and maintenance expenses related to the properties. Certain of these leases contain renewal or purchase options exercisable at the end of the lease terms.
Business Outlook
A majority of our revenue growth is expected to continue to come from the Asia region, predominantly China. In response to this expectation, we have entered into a joint venture that completed the construction of an IC research and development and manufacturing facility in Xiamen, China, in late 2018; Production commenced at this facility in Q3 FY19. In addition, in August 2017, we entered into an investment agreement to construct an FPD manufacturing facility in Hefei, China. Construction of this facility was completed in late 2018, and production commenced in the second quarter of 2019.
We make continual assessments of our global manufacturing strategy and monitor our revenue and related cash flows from operations. These ongoing assessments could result in future facility closures, asset redeployments, impairments of intangible or long-lived assets, workforce reductions, or the addition of increased manufacturing facilities, all of which would be based on market conditions and customer requirements.
Our future results of operations and the other forward-looking statements contained in this filing involve a number of risks and uncertainties. While various risks and uncertainties were discussed in Part1, Item 1A in our Annual Report on Form 10-K for the year ended October 31, 2018, a number of other unforeseen factors could cause actual results to differ materially from our expectations.
Effect of Recent Accounting Pronouncements
See “Item 1. Condensed Consolidated Financial Statements – Notes to Condensed Consolidated Financial Statements – Note 14 – Recent Accounting Pronouncements” for recent accounting pronouncements that may affect the Company’s financial reporting.
Foreign Currency Exchange Rate Risk
We transact in a number of different currencies throughout our worldwide operations, and our financial performance may be affected by fluctuations in the exchange rates of these currencies. Changes in exchange rates can positively or negatively affect our reported revenue, operating income, assets, liabilities, and equity. The functional currencies of our Asian subsidiaries are the South Korean won, the New Taiwan dollar, the Chinese renminbi and the Singapore dollar. The functional currencies of our European subsidiaries are the British pound and the euro. In addition, we engage in transactions and have exposures to the Japanese yen.
We attempt to minimize our risk of foreign currency transaction losses by producing products in the same country in which the products are sold (thereby generating revenues and incurring expenses in the same currency), and by managing our working capital. However, in some instances, we sell and collect for products in a currency other than the functional currency of the country where it was produced, or purchase products in a currency that differs from the functional currency of the purchasing entity. In addition, to the extent practicable, we attempt to reduce our exposure to foreign currency exchange fluctuations by converting cash and cash equivalents into the functional currency of the subsidiary which holds the cash. We may also enter into derivative contracts to mitigate our exposure to foreign currency fluctuations when we have a significant purchase obligation or significant receivable denominated in a currency that differs from the transacting subsidiaries’ functional currencies. We do not enter into derivatives for speculative purposes. There can be no assurance that our attempts to minimize our foreign currency exchange rate risks will protect us from the need to recognize significant foreign currency transaction gains and losses, especially in the event of a significant adverse movement in the value of any foreign currency in which we conduct business against any of our functional currencies, including the U.S. dollar.
As of July 28, 2019, a 10% adverse movement in the value of currencies different than the functional currencies of the Company or its subsidiaries would have resulted in a net unrealized pre-tax loss of $34.0 million, which represents an increase of $20.8 million from our exposure at October 31, 2018. The increase in foreign currency rate change risk is primarily the result of increased exposures of the Chinese renminbi, South Korean won, and New Taiwan dollar against the U.S. dollar. We do not believe that a 10% change in the exchange rates of non-US dollar currencies, other than the aforementioned currencies and the Japanese yen, would have had a material effect on our July 28, 2019, condensed consolidated financial statements.
Interest Rate Risk
A 10% adverse movement in the interest rates on our variable rate borrowings would not have had a material effect on our July 28, 2019, condensed consolidated financial statements.
Evaluation of Disclosure Controls and Procedures
We have established and currently maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), designed to provide reasonable assurance that information required to be disclosed in reports filed under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to management, including our chief executive officer and chief financial officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost—benefit relationship of possible controls and procedures.
Our management, under the supervision and with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of the end of the period covered by this report.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting during the third quarter of fiscal year 2019 that has materially affected, or is reasonably likely to materially effect, our internal control over financial reporting.
PART II. OTHER INFORMATION
There have been no material changes to risks relating to our business as disclosed in Part 1, Item 1A of our Form 10-K for the year ended October 31, 2018.
Issuer Purchases of Equity Securities
In October 2018, the Company’s board of directors authorized the repurchase of up to $25 million of its common stock, to have been executed in open-market transactions or in accordance with a repurchase plan under rule 10b5-1 of the Securities Act of 1933 (as amended). The repurchase program was terminated on February 1, 2019.
Total Number of Shares Purchased (in millions) |
Average Price Paid Per share |
Total Number of Shares Purchased as Part of Publicly Announced Program (in millions) |
Dollar Value of Shares That May Yet Be Purchased (in millions) |
|||||
Period |
||||||||
October 12, 2018 – October 31, 2018 |
0.3 |
$9.45 |
0.3 |
$21.9 |
||||
November 1, 2018 – November 25, 2018 |
0.2 |
$9.49 |
0.2 |
$20.1 |
||||
November 26, 2018 – December 23, 2018 |
0.7 |
$9.38 |
0.7 |
$13.4 |
||||
December 24, 2018 – January 27, 2019 |
0.2 |
$9.41 |
0.2 |
$11.2 * |
||||
Total |
1.4 |
1.4 |
* The share repurchase program was terminated on February 1, 2019, with no additional shares being purchased subsequent to January 27, 2019.
Effective July 25, 2019, the Company entered into a Master Lease Agreement (“MLA”) with Banc of America Leasing and Capital LLC (the Company received the MLA fully executed by the counter party on September 3, 2019) which enables us to request advance payments or other funds for equipment or enter into an equipment lease in the U.S. In connection with this MLA, we were approved for financing of $35 million for the purchase of equipment; as of July 28, 2019, we had no outstanding borrowings against this MLA. In the fourth quarter of fiscal 2019, the financing entity, upon our request, made an advance payment of $3.4 million to an equipment vendor on our behalf. Interest on this borrowing is payable monthly at thirty-day LIBOR plus 1%, and will continue to accrue until the borrowing is repaid or, as allowed under the MLA, we enter into a lease for the equipment. All borrowings under the MLA are secured by the equipment purchased or financed.
Incorporated by Reference |
||||||||
Exhibit Number |
Description |
Form |
File Number |
Exhibit |
Filing Date |
Filed or Furnished Herewith |
||
Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
X |
|||||||
Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
X |
|||||||
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
X |
|||||||
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
X |
|||||||
Master Lease Agreement Number: 48869-90000 between the Company and Banc of America Leasing & Capital, LLC dated July 25, 2019 |
X |
|||||||
101.INS |
XBRL Instance Document |
X |
||||||
101.SCH |
XBRL Taxonomy Extension Schema Document |
X |
||||||
101.CAL |
XBRL Taxonomy Extension Calculation Linkbase Document |
X |
||||||
101.DEF |
XBRL Taxonomy Extension Definition Linkbase Document |
X |
||||||
101.LAB |
XBRL Taxonomy Extension Label Linkbase Document |
X |
||||||
101.PRE |
XBRL Taxonomy Extension Presentation Linkbase Document |
X |
||||||
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Photronics, Inc. |
||
(Registrant) |
||
By: |
/s/ JOHN P. JORDAN |
|
JOHN P. JORDAN |
||
Senior Vice President |
||
Chief Financial Officer |
||
(Principal Accounting Officer/ |
||
Principal Financial Officer) |
Date: September 4, 2019
34
